In 2025, children within the TEDDY study will submit their final samples at research clinics in Sweden, Finland, Germany and ...

Researchers suggest that this treatment approach could be applied to various cancer types by focusing on the tumour ...

For Dr. Daniel Gilada, a husband, physician and soon-to-be father of four, living with Type 1 diabetes had become “overwhelming ... and Gilada are taking part is testing a new monoclonal antibody, ...

In a study published in Cell Reports, researchers from Prof. Idit Shachar's laboratory at the Weizmann Institute of Science ...

Findings indicate younger-onset type 2 diabetes is associated with higher mortality and complications, highlighting the need ...

Dr. Piotr Witkowski, director of the pancreatic and islet transplant program at the University of Chicago Transplant ...

CHICAGO — A real-world study of the ocular side effects of the gynecological cancer treatment mirvetuximab (Elahere) has ...

Objectives Systemic sclerosis (SSc) is a heterogeneous disease, complicating its management. Its complexity and the ...

Crescent Biopharma is advancing a drug its CEO claims is “purpose-built” to be a perfected version of Summit Therapeutics’ ...

(This Oct. 17 story has been corrected to say that the drug reduced some types of respiratory infection, not all, in the ...

PRNewswire/ -- "According to the latest BCC Research study, "The global ADCs market is showing a rapid growth trend, with ...

(MENAFN- IANS) Jerusalem, Nov 4 (IANS) Israeli researchers and their colleagues from the United States developed an ...